Shortened Exclusivity Could Save $31B Alex Brill was recently quoted by Politico Pro about MGA’s recent “Gamesmanship and Other Barriers to Drug Competition” paper: “Brand-name medicines’ market exclusivity periods have climbed an average...
Observable Flaws in CMS’s Dialysis Star-Rating System and a Proposed Alternative Alex Brill | Bloomberg BNA In January 2015, CMS launched a star-rating system for U.S. dialysis facilities. This article analyzes nearly 6,000 U.S. dialysis facilities and explores...
